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Suliman Mansi1*, Stephan Milosavljevic2, Steve Tumilty1, Paul Hendrick3 and G David Baxter1Abstract
Background: Current evidence supports the use of pedometers as effective motivational tools to promote physical
activity and improve health-related quality of life in the general population. The aims of this study are to examine
whether a pedometer-driven walking programme can improve health-related quality of life, and increase ambulatory
activity in a population of meat processing workers when compared to a control group receiving educational
material alone.
Methods/design: A feasibility study employing a randomized controlled trial (RCT) design will collect data at
three time points. A sample of up to 60 meat workers will be recruited and randomly assigned to either an
intervention group N = 30 (12-week pedometer-driven walking program, brief intervention, and educational material),
or control group N = 30 (educational material only). The primary outcomes of ambulatory activity, health-related quality
of life, and functional capacity, will be evaluated at baseline, immediately following the 12-week intervention and then
at three month post-intervention.
Discussion: This paper describes the design of a feasibility randomized controlled trial, which aims to assess the
effectiveness of the introduction of a workplace pedometer-driven walking program compared to normal lifestyle
advice in meat processing workers.
Trial Registration Number: (ANZCTR): 12613000087752.
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The meat processing industry is the second most im-
portant sector in the New Zealand (NZ) economy,
employing approximately 24,000 workers, and contrib-
uting approximately 13% of New Zealand’s exports [1].
Meat processing involves different work stages that in-
clude slaughtering, boning, cutting, and packing, which
demand different physical workloads and tasks. These
often require prolonged periods in task-related non-
neutral postures, potentially leading to an increased risk
of occupational injuries.* Correspondence: almsu521@student.otago.ac.nz
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reproduction in any medium, provided the orWork-related disorders and occupational injuries re-
ported to afflict workers in the meat processing industry
are varied, with musculoskeletal disorders (MSD) being
a commonly reported health problem [2-4]. Relevant risk
factors include hazardous working conditions [4,5] with
repetitive movements, heavy physical workload, and sus-
tained standing [6-8] that have been linked to increased
levels of disability, sick leave, and work incapacity [9].
The prevalence of MSD among meat processing workers
has been previously published [2]. For example meat
processing in the USA is considered one of the most
hazardous industries, with an overall incidence injury
rate of 6.9 per 100 fulltime workers in 2009 [10], while
in Canada, the incidence injury rate was 23.48 per 1,000
[11]. In NZ the prevalence of MSD is at a higher ratetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Corporation (ACC) claims data in 2005–2006, with annual
cost of approximately $12 million [12] while in 2003, the
MSD incidence rate for meat processing was 59 per 1000
full-time equivalent workers (FTE) compared to 20 per
1000 FTE for forestry and logging and 16 per 1000 FTE
for construction [12]. The most common injuries usually
involve the upper extremities [13-15], with shoulder, and
neck, as well as lower back, having the highest reported
incidence [13,16-23].
These conditions are known to impact on health-related
quality of life, increase healthcare costs, and also decrease
daily activities [24]. It has also been reported that adults
with MSD have an overall poorer health-related quality of
life than the general population reporting no pain [24,25];
this effect is likely to be increased among aging employees
due to the health problems that accrue over a working
life-span.
Improving general health status by increasing the level
and capacity for physical activity (PA) may help lead to a
reduction in occupational injury and protect workers
from accidents; reduce working hours lost as a result of
absence due to illness or injury; as well as reduce the
costs of treatment, and claims for compensation [26-28].
Physical activity (PA) plays an important role in the
prevention and management of various chronic diseases
including sedentary obese, high blood pressure, and car-
diovascular disease [29-31], with a reduction in prema-
ture mortality and improvement in quality of life [32].
Studies have demonstrated the benefit of increased PA
in reducing pain and improving quality of life in workplace
populations with MSD [33,34]; levels of PA also correlate
with reductions in the risk for premature all-cause mortal-
ity across all groups and sexes in the general population
[35,36]. A critical review by Propper and colleagues
identified clear evidence for the benefit of worksite PA
to manage MSD among employees [37]. Currently,
there are studies that support the use of walking-based
interventions that encourage people with MSD (includ-
ing LBP, osteoporosis, hip, and knee osteoarthritis
[38-42] to assume a physically active role in their recovery.
A recent publication has also demonstrated the effect of
pedometer-driven walking on relieving musculoskeletal
symptoms (for both function and pain) in chronic LBP
among adults aged 18 or over [43].
National and international PA guidelines have recom-
mended that every adult accumulate at least 150 minutes
of moderate-to-vigorous intensity physical activity every
week, to gain significant health benefits [44]. Despite
the well-known benefits of regular PA, the World
Health Organization (WHO) reported in 2008, that 31%
of adults over 15 years exhibit a sedentary lifestyle, and
have a 20-30% increased risk of mortality compared to
active people, with this effect being more noticeableamong females compared to males [45,46]. Although
The New Zealand Physical Activity Guidelines state that
adults should participate in at least 30 minutes of mod-
erate activity on most, if not on all days of the week [47]
data from Sport and Physical Activity Surveys NZ 2008
[48] show that only 48.2% of NZ adults are physically
activity on five or more days per week, while a recent
New Zealand Health Survey 2012 [49], found 54% of
adults met the current recommendations of daily PA daily.
Physical inactivity is a significant public health issue in
New Zealand [45] contributing to non-communicable
diseases and health problems; costing approximately
$1.3 billion for the 2010 year [50].
Walking is considered to be an ideal form of PA to pro-
mote and maintain health status in the general population.
For most it requires no additional physical skills, and is
achievable by all ages with little risk of injury [51,52]. A
systematic review [53] examined the effectiveness of
interventions aimed to promote walking that including
19 randomised controlled trials and 29 non-randomised
controlled studies. The review concluded that the stron-
gest evidence exists for tailored interventions that fo-
cused at the level of the individual needs and sedentary
groups such as pedometers with individual goal setting
to be more effective to promote walking.
Walking with a pedometer as the intervention tool is be-
coming widely used in different health related domains to
promote PA levels, and improve health status in a wide
range of populations. Pedometers can supply valuable in-
formation on the number of steps and distance travelled,
time spent in an activity, and also provide an estimate of
energy expenditure [54]. The majority are a reliable and
valid device for increasing and measuring physical activity,
particularly as part of a walking programme [55]. In
clinical studies pedometers have been widely used in
the assessment and management of PA within a range
of conditions including sedentary obese [56,57], dia-
betes [58], and knee osteoporosis [39,59], with an aim
to encourage increased habitual physical activity, and
improve health-related quality of life.
A variety of workplace pedometer walking interventions
have been developed to improve health-related outcomes
and increase the PA levels of employees [60,61]. Workplace
pedometer-based interventions with goal setting (such as
10,000 steps per day) and weekly e-mail messages have
shown a positive effects on PA and health outcomes in the
short-term [62,63] as well as long-term [64]. Correlations
between number of steps and health outcomes have been
shown [60,61,64]: for example Chan and colleague [65] re-
ported in group of intervention an average daily step count
increase of 3,451 ± 2,661 with a concurrent significant
decrease in body mass index and waist girth. These re-
sults illustrate the potential that the workplace offers as
an ideal setting for health promotion and PA strategies.
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driven walking as a motivational strategy and intervention
together with goal setting in order to increase daily ambu-
latory activity among meat processing workers. The meat
industry has substantial economic importance to the New
Zealand economy. However it is known that the popula-
tion of meat-workers in New Zealand is aging and has
health related issues consistent with an aging population,
a sedentary lifestyle, and chronic disease that include obes-
ity, hypertension, diabetes, and other cardiopulmonary
problems [66,67]. Although these factors can impact ad-
versely on work productivity and sick leave [9], they are
also known to positively respond to increased PA [29,30].
A healthier more active work force will likely be associ-
ated with reduced sick leave, reduced injury rates, and
increased productivity [60]. The use of a simple, cheap,
performance driven physical intervention, and one that
is socially interactive, may be a significant step towards
improving the health and lifestyle of these workers.
The primary aims of this study are to examine whether
a pedometer-driven walking programme, incorporating a
brief intervention, along with an educational material
can improve health-related quality of life, and increase
ambulatory activity in a population of meat processing
workers when compared to a control group receiving
educational material alone. Secondary effects on blood
pressure, body mass index, body fat percentage, and waist
circumference will be also measured. We hypothesize that
the pedometer-driven walking intervention will be a
feasible and effective tool to increase participants’ daily
ambulatory activity levels and improve health outcomes
compared to a control group.Methods/design
Study design
This will be a feasibility study using a randomized con-
trolled trial (RCT) design. Data will be collected at three
time points (baseline, 12 weeks (at conclusion of inter-
vention), and 3 months post intervention). The study
will recruit up to 60 participants and comprise two arms
(i) pedometer-driven walking (PW) n =30), (ii) control
group receiving normal lifestyle advice (CG n = 30).This
randomised clinical trial will be reported according to
the recommendations of the CONSORT statement [68].Ethical approval
The study design has been approved by the Otago Human
Ethics Committee number (12/313) and the study proto-
col is registered on the Australian New Zealand Clinical
Trials Registry (ANZCTR): 12613000087752. Written in-
formed consent will be obtained before participants enter
the study.Description and selection criteria of participants
A large, local meat processing plant in the South Island of
New Zealand (with 900 people working in 12 depart-
ments) has agreed to participate in the study. Employee
recruitment will be through advertisements (posters) in
different work-sites including the health clinic, plant ad-
ministration, cafeterias, and all department notice-boards
until a target sample (n = 60) is achieved. Participants will
eligible to participate if they are: currently working, male
or female aged 18–65 years, have a sedentary lifestyle and/
or low levels of physical activity (less than 7,499 steps per
day); are able to walk continuously for at least 10 minutes;
able to read and sign an informed consent form and ques-
tionnaires, and are willing to participate for the full study
duration.Screening
Potential participants will initially be screened for eligibil-
ity for entry into the randomized control trial by wearing
the pedometer (Yamax Digi-walker SW-200) for seven
consecutive days. Participants will be instructed on how to
wear and use the pedometer at the assigned location on a
waist band above the lateral hip during all waking hours,
except for periods immersed in water (bathing, swim-
ming), during certain sporting activities (playing basketball
or soccer, etc.), or in bed at night. They will be instructed
to reset the pedometer to zero at the beginning of each
day, and remove it at the end of each day, record on a step
calendar the date and the time pedometer was attached
and also removed, and the total number of steps displayed
on the pedometer at the end of each day.
Participants who have accumulated an average of 7,500
or more steps per day will be excluded before baseline as-
sessment. In addition, the ability of the participant to be
physically able to participate in walking program will be
screened using the physical activity readiness question-
naire (PAR-Q) [69]: if a participant answers yes to one or
more questions on the PAR-Q, they will be advised to con-
sult their healthcare provider and that physician consent
will be required prior to program participation.Randomization
After successfully completing the baseline assessment and
signing the informed consent form, randomization to one
of the two groups will be performed using sealed enve-
lopes. Participants will be invited to choose an envelope
from a basket containing envelopes that allocate 50% of
the sample for the intervention and the other 50% for the
control groups: each will contain the group name for allo-
cation, and the timetable of the study. Researchers and
participants will be not be blinded to group allocation.
The assessor for final outcome measurements will be
blinded to group allocation until the final assessment is
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process and randomisation is presented in Figure 1.
Outcome measurements and methods
The outcome measurements will be made at baseline,
immediately after the 12 week pedometer-driven walking
programme (and equivalent for control group), and at
the 3 month follow-up time point. Data from all outcome
measures will be securely stored and only analysed once
the trial is complete. The primary outcome measurements
are quality of life, PA level, and functional capacity. Sec-
ondary outcome measures will include blood pressure
(BP), body mass index (BMI), body fat percentage (BF),
and waist circumference (WC).
Health-related quality of life
This will be measured using The Short Form 36
version2 (SF-36v2) questionnaire. The SF-36v2 has been
widely used to measure quality of life in general and
specific populations [70,71]. It has eight domains of
health-related quality of life: physical functioning, role
limitations resulting from physical health problems,
bodily pain, social functioning, general mental health,Assessed for s
Consent and Ran
Intervention group   
N=30  
Week 12: Assessment: Immedia
Week 24: Assessm
Figure 1 Trial protocol.role limitations resulting from emotional problems, vital-
ity, and general health problems. The SF-36 questionnaire
has been validated and is a reliable measure of physical
and mental health that can be completed in five to ten
minutes [71,72].
Ambulatory activity levels PA
Objective change in PA level will be measured using a
pedometer. The Yamax Digi-walker SW-200(Yamax,
Tokyo, Japan) will be used in this study. This model
demonstrates acceptable reliability for research pur-
poses in the adult population [73,74]. It was found to
be the most accurate pedometer in counting steps, re-
cording between 1-3% error within both free living
and controlled laboratory settings [75-77]; it has been
found to most accurately record at walking speeds of
80–107 m.min-1 [78,79]. Each participant will also com-
plete the International Physical Activity Questionnaire
short form (IPAQ-SF), which was developed as an in-
strument to measure health-related physical activity in
work age populations, and is a valid and reliable meas-
ure for monitoring population levels of physical activ-
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ing aerobic activities vigorous-intensity, cycling activities
moderate-intensity, walking activities, and sitting time in
the last seven days [80,83].
Functional exercise capacity
Functional exercise capacity will be measured using the
Six Minute Walk Test (6MWT). The 6MWT is a self-
paced task that has been used to assess functional exercise
capacity within a variety of chronic conditions, as well as
in healthy adults [84,85]. It is a practical and simple test
which does not require expensive equipment or advanced
training for technicians, and only requires a 100-ft walk-
way. The test involves asking people to walk the longest
distance possible on an over-ground, hard surface in a
period of 6 minutes. It has been shown to have good reli-
ability and validity when used to assess functional capacity
[86,87]. These walks will be performed on a smooth level
surface in an under-cover area, using a straight 30 meter
line marked off in 5 m segments by a piece of adhesive
tape. Technicians will encourage participants with stan-
dardized statements such as You’re doing well, Keep up
the good work, and do your best, and the total distance
walked will be recorded in meters. Percent predicted
values for 6MWT will be calculated using the regression
equation described by Enright & Sherrill [88].
Physical activity self-efficacy scale
The five point scale of Self-efficacy will be adminis-
tered to assess participants’ beliefs or their confidence
in their physical ability to successfully achieve their
goals in different situations [89]. The questionnaire
consists of 5 questions and response should take no
longer than one minute which scored by summing a 5
point Likert scale ranging from (1 = not at all confident to
5 = extremely confident) with a higher score reflecting
greater self-efficacy for exercise. This scale has been
shown to have acceptable two week test-retest reliability
(0.90) and an internal consistency coefficient of 0.78 [89].
Anthropometric and physiological measures
During baseline, 12-week, and follow-up 3 months as-
sessments, several secondary measures will be obtained
in both intervention and control groups including blood
pressure (BP), body mass index (BMI), body fat (BF),
waist circumference (WC), height and weight.
Blood pressure will be measured with an Omron MX3
Plus Blood Pressure Monitor (HEM-7200-E) [90] on 3
occasions with a rest period of one minute between
measurements.
Body Mass Index (BMI) will be calculated as recorded
mass divided by height squared.
Body Fat Percentage will be formulaically measured
using skinfold thickness (The Harpenden Skinfold CaliperW/Software) which was taken from four sites (triceps,
biceps, subscapular, and suprailiac) according to recom-
mended locations and technique [91,92]. Three mea-
surements to the nearest 0.1 mm will be taken averaged
then will be recorded on the report survey. Body fat will
be calculated by Linear Software (Durnin and Womersley)
[93] which valid for people between 17 and 68 years
old: body fat = (triceps + biceps + subscapular + suprailiac
skinfolds) according to the participant’s weight kg and
age [93,94].
Waist Circumference will be measured using plastic tape
by placing it around the waist at the level of the umbilicus
(iliac crest).
Height and Weight will be measured without shoes
and light clothing using commercially available digital
bathroom scales (Terraillon Lovely Classic Electronic
Bath Scale) to assess weight which can weigh in 100G
increments up to a maximum of 150 Kgs, and a standard
laboratory stadiometer (Seca 213 Portable Stadiometer)
to measure height.Sample size
Sample size calculations for effectiveness will be not
performed. As this will be a feasibility study, one of the
aims of data collection will be to determine the effect of
the intervention which will then allow size calculations
for an adequately powered RCT. However, we will invite
the pool of ≈ 900 workers from a local meat processing
plant on the South Island of New Zealand to consider
participating in the study. Volunteer participants will be
screened and the study will begin when the first 60 par-
ticipants who meet eligibility criteria have been recruited
(N =30 participants each group).Statistical analysis
Statistical analysis will be performed using SPSS software
20.0, and will include descriptive data and means, confi-
dence intervals, and the standard deviation from the
mean. This will be determined for all outcome measures
recorded at baseline, 12-week, and the follow-up meas-
urement (3 months after the intervention).
The feasibility and acceptably of using pedometers as an
intervention to promote ambulatory activity and improve
health outcomes in this population will be evaluated
through participant satisfaction with the intervention by
using survey questionnaire about pedometer usage after
completion the intervention. Participants will be asked
about participation in the intervention, and about their
satisfaction with participation. Details of the questionnaire
were described elsewhere [95]. In addition, adherence to
the pedometer-driven walking program by using pedom-
eter logs to determine the number of days that pedometer
was worn and divided by the total number of intervention
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All potential participants will be instructed to wear the
pedometer on the waistband of their clothing for seven
days, based on previous study protocols [96-99] in order
to establish baseline step-counts during normal daily
activity. Tudor-Locke and Bassett [52] have classified
pedometer-determined PA in adults by an average step
count of less than 5,000 steps/day as a sedentary life-
style, and 5,000 to 7,499 steps per day as low activity;
therefore, participants who accumulate an average base-
line step count of 7,500 steps per day or more will be
excluded; remaining participants will be randomized to
one of the two groups. Baseline outcomes measures were
collected during the seven days pedometer assessment
including the primary and secondary outcomes. After
randomization, all participants will attend a 30 minute
education session on the health benefits of being phys-
ically active, then participants in the walking group will
receive a brief intervention group session of up to
70 minutes, including a 10 minute self-efficacy walk, a
30 minute session focussing on physical activity behav-
iour change, and 30 minutes focused on the education
resource material (physical activity and PA booklet).
This intervention session will be based on the Back2-
Activity protocols [100] and conducted by physiothera-
pists (including one with training in motivational
interviewing), and student researcher.
Intervention protocol
The 12 week pedometer-driven walking intervention will
be based on self-regulation theory (SRT) [101] and in-
clude goal setting, feedback, educational material, and
the use of a step calendar for self-monitoring. Partici-
pants will be required to walk for at least five days per
week to meet evidence based international guidelines
that recommend adults to accumulate at least 30 minutes
of moderate intensity activity, on at least five days/week,
to achieve optimal health benefits [102].
Educational materials
Participants in both the walking (intervention group)
and control groups will also receive standardised educa-
tional material that consists of written and graphical in-
formation describing the importance of walking as a PA
for health benefits and prevention of disease [29,30].
Goal setting
At the beginning of each week, participants will receive a
weekly email reminder about his or her step-count goal
for that week based on their baseline walking activity level;the goal will aim to gradually increase the level of activities
by 5% from their previous goal setting target with an aim
to reach at least 10,000 steps per day at the end of the
12 week period. These targets are based on international
guidelines for walking interventions [52]. However for
those who reached 10,000 steps per day at any time during
the program will be also encouraged to maintain and
increase their physically active lifestyle.
Step count and feedback
Participants in the intervention group will receive perman-
ent step-count feedback by looking at the digital display
on the pedometer monitor. Participants will also receive
personalized weekly emails about daily average step-count
and additional health information, to encourage their ad-
herence with the program.
Step calendar
Participants in the walking group will be given a diary to
record their walks and note each day as to whether they
are adhering to the program, the time of day, duration
of the walk, the week’s step-count goal, and the number
of steps taken at the end of each day.
Control group
Participants randomly allocated to the control group will
be encouraged to read the educational activity material
and be asked to record any exercise they perform over
the 12 weeks. At the completion of the 12 weeks, and at
the follow up at 24 weeks, these participants will again
wear the pedometer for one week to establish a weekly
step count for comparison to baseline scores.
Discussion
Although pedometer-driven walking has been increasingly
investigated as a management strategy for chronic disease
and workplace populations, there has been no previous
study of their use as an intervention for meat processing
workers. This study will focus on a walking program as a
management strategy for those populations. Results of this
feasibility study will be used to inform the development of
a future fully-powered controlled trial of the effectiveness
of this intervention in this population.
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